Home / Letter From The Editor (page 92)

Letter From The Editor

Letter from the Editor #703:

This week there was a change in guidelines concerning the use of cholesterol lowering medications. New guidelines from the American College of Cardiology and the American Heart Association (ACC/AHA) point towards as much as a 30% increase in patients where statins are indicated. In addition the Obesity Society weighed (no …

Read More »

Letter from the Editor, #702

For the last year we have had a generic version of the alpha glucosidase inhibitor, Acarbose. Many of you would never prescribe this medication because of the possible side effects of gas and gastric discomfort. In addition there did not appear to be a real benefit as far as A1c …

Read More »

Editor’s Note, DCMS #161

Over the past few years there has been a decrease in the ability of clinicians to diagnose and treat patients. According to a study in The Lancet, this decrease in diagnostic ability can be partly blamed on the increased use of smartphones and other devices that deliver information to a …

Read More »